{
      "Rank": 989,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "human mesenchymal stem cells:1*10^4-6 cells /Kg , IV (in the vein) on day 1 of each 14-60 day cycle,1-6 times treatment, plus non-steroid anti-inflammatory drugs (NSAID: \"celecoxib\", \"Celebrex\u00ae\" 0.2g Bid(twice a day),PO (Per Os).\n\nDuration of treatment:24 weeks for follow up. collect peripheral blood (PBMCs and serums)of those patients at baseline and every 4 weeks for basic study after they signed informed consent.",
            "non-steroid anti-inflammatory drugs (NSAID: \"celecoxib\", \"Celebrex\u00ae\" 0.2g Bid(twice a day),PO (Per Os);a total of 24 weeks for follow up;collect peripheral blood (PBMCs and serums)of those patients at baseline and every 4 weeks for basic study after they signed informed consent."
      ],
      "ArmGroupInterventionName": [
            "Biological: MSC",
            "Drug: \"celecoxib\", \"Celebrex\u00ae\"",
            "Drug: \"celecoxib\", \"Celebrex\u00ae\""
      ],
      "ArmGroupLabel": [
            "MSC plus NSAID",
            "NSAID"
      ],
      "ArmGroupType": [
            "Experimental",
            "Experimental"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT01709656"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "The investigators will recruit active ankylosing spondylitis patients for injection treatment of Human Mesenchymal Stem Cells (a prospective, open-label, masculine medicine controlled(NSAIDs), clinical trial), and collect their Peripheral Blood Lymphocyte (PBMCs) and sera before and after the treatment of 24 weeks to test the gene expression profiles and study related pathogenesis of AS"
      ],
      "BriefTitle": [
            "A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis"
      ],
      "CentralContactEMail": [],
      "CentralContactName": [],
      "CentralContactPhone": [],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [],
      "CollaboratorClass": [],
      "CollaboratorName": [],
      "CompletionDate": [
            "December 2014"
      ],
      "CompletionDateType": [
            "Actual"
      ],
      "Condition": [
            "Ankylosing Spondylitis"
      ],
      "ConditionAncestorId": [
            "D000001850",
            "D000007239",
            "D000001847",
            "D000009140",
            "D000013122",
            "D000001168",
            "D000007592",
            "D000025242",
            "D000000844"
      ],
      "ConditionAncestorTerm": [
            "Bone Diseases, Infectious",
            "Infections",
            "Bone Diseases",
            "Musculoskeletal Diseases",
            "Spinal Diseases",
            "Arthritis",
            "Joint Diseases",
            "Spondylarthropathies",
            "Ankylosis"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC01",
            "BC05",
            "All",
            "BC23",
            "Rare"
      ],
      "ConditionBrowseBranchName": [
            "Infections",
            "Musculoskeletal Diseases",
            "All Conditions",
            "Symptoms and General Pathology",
            "Rare Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Spondylitis",
            "Spondylitis",
            "Ankylosing Spondylitis"
      ],
      "ConditionBrowseLeafId": [
            "M15113",
            "M22188",
            "M15114",
            "M9435",
            "M5520",
            "M4278",
            "M4281",
            "M11249",
            "M15071",
            "M3628",
            "M9773",
            "M22189",
            "M3322",
            "T5412"
      ],
      "ConditionBrowseLeafName": [
            "Spondylitis",
            "Spondylarthritis",
            "Spondylitis, Ankylosing",
            "Infections",
            "Communicable Diseases",
            "Bone Diseases",
            "Bone Diseases, Infectious",
            "Musculoskeletal Diseases",
            "Spinal Diseases",
            "Arthritis",
            "Joint Diseases",
            "Spondylarthropathies",
            "Ankylosis",
            "Spondylarthropathy"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000013166",
            "D000025241",
            "D000013167"
      ],
      "ConditionMeshTerm": [
            "Spondylitis",
            "Spondylarthritis",
            "Spondylitis, Ankylosing"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nAged from 16-65 years, sign the Informed Consent\nFulfill 1984 modified NewYork classification criteria for AS\nHave an active refractory disease defined by a score \u226540 on the Bath AS Disease Activity Index (BASDAI) (0-100) despite optimal non-steroidal anti-inflammatory drug (NSAID) treatment.\nCommitment to contraceptive for woman\n\nExclusion Criteria:\n\nCompletely stiff spine\nReceived spinal or joint surgery within 2 months\nReceived anti-TNF therapy within 3 months\nHistory of the listed diseases: heart failure, Multiple sclerosis, severe chronic obstructive pulmonary disease, frequent infections, lymphoma or other cancers, tuberculosis\nFemale of pregnancy or breast feeding\nHb\u2264 9g/dl for male or Hb \u2264 8.5 g/dl for male, ALT/AST\u22652folds of upper level normal range, Creatine\u2265120mol/L(\u22641.4mg/dl)"
      ],
      "EnrollmentCount": [
            "120"
      ],
      "EnrollmentType": [
            "Actual"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [
            "D000000894",
            "D000018712",
            "D000000700",
            "D000018689",
            "D000018373",
            "D000045505",
            "D000000893",
            "D000018501",
            "D000052246",
            "D000016861",
            "D000004791",
            "D000045504"
      ],
      "InterventionAncestorTerm": [
            "Anti-Inflammatory Agents, Non-Steroidal",
            "Analgesics, Non-Narcotic",
            "Analgesics",
            "Sensory System Agents",
            "Peripheral Nervous System Agents",
            "Physiological Effects of Drugs",
            "Anti-Inflammatory Agents",
            "Antirheumatic Agents",
            "Cyclooxygenase 2 Inhibitors",
            "Cyclooxygenase Inhibitors",
            "Enzyme Inhibitors",
            "Molecular Mechanisms of Pharmacological Action"
      ],
      "InterventionArmGroupLabel": [
            "MSC plus NSAID",
            "MSC plus NSAID",
            "NSAID"
      ],
      "InterventionBrowseBranchAbbrev": [
            "Infl",
            "ARhu",
            "Analg",
            "All",
            "AnObAg",
            "VaCoAg",
            "Resp"
      ],
      "InterventionBrowseBranchName": [
            "Anti-Inflammatory Agents",
            "Antirheumatic Agents",
            "Analgesics",
            "All Drugs and Chemicals",
            "Anti-Obesity Agents",
            "Vasoconstrictor Agents",
            "Respiratory System Agents"
      ],
      "InterventionBrowseLeafAsFound": [
            "SARS-"
      ],
      "InterventionBrowseLeafId": [
            "M277",
            "M3369",
            "M12722",
            "M8390",
            "M186171",
            "M3370",
            "M3184",
            "M19939",
            "M19757",
            "M26162",
            "M18361"
      ],
      "InterventionBrowseLeafName": [
            "Celecoxib",
            "Anti-Inflammatory Agents",
            "Phenylpropanolamine",
            "Guaifenesin",
            "Chlorpheniramine, phenylpropanolamine drug combination",
            "Anti-Inflammatory Agents, Non-Steroidal",
            "Analgesics",
            "Analgesics, Non-Narcotic",
            "Antirheumatic Agents",
            "Cyclooxygenase 2 Inhibitors",
            "Cyclooxygenase Inhibitors"
      ],
      "InterventionBrowseLeafRelevance": [
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "InterventionDescription": [
            "human mesenchymal stem cells,1*10^4-6 cells /Kg , IV (in the vein) on day 1 of each 14-60 day cycle,1-6 times treatment.\n\na total of 24 weeks for follow up.",
            "non-steroid anti-inflammatory drugs (NSAID):\"celecoxib\", \"Celebrex\u00ae\" 0.2g Bid(twice a day),PO (Per Os);a total of 24 weeks for follow up"
      ],
      "InterventionMeshId": [
            "D000068579"
      ],
      "InterventionMeshTerm": [
            "Celecoxib"
      ],
      "InterventionName": [
            "MSC",
            "\"celecoxib\", \"Celebrex\u00ae\""
      ],
      "InterventionOtherName": [],
      "InterventionType": [
            "Biological",
            "Drug"
      ],
      "IsFDARegulatedDevice": [],
      "IsFDARegulatedDrug": [],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "February 11, 2015"
      ],
      "LastUpdatePostDateType": [
            "Estimate"
      ],
      "LastUpdateSubmitDate": [
            "February 10, 2015"
      ],
      "LeadSponsorClass": [
            "OTHER"
      ],
      "LeadSponsorName": [
            "Sun Yat-sen University"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Guangzhou"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [],
      "LocationCountry": [
            "China"
      ],
      "LocationFacility": [
            "Department of Rheumatology, the Third Affiliated Hospital of Sun Yat-sen University"
      ],
      "LocationState": [
            "Guangdong"
      ],
      "LocationStatus": [],
      "LocationZip": [],
      "MaximumAge": [
            "65 Years"
      ],
      "MinimumAge": [
            "16 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis"
      ],
      "OrgClass": [
            "OTHER"
      ],
      "OrgFullName": [
            "Sun Yat-sen University"
      ],
      "OrgStudyId": [
            "[2012]2-31"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "Department of Rheumatology , Third Affiliated Hospital of Sun Yat-sen University"
      ],
      "OverallOfficialName": [
            "Jieruo Gu, M.D."
      ],
      "OverallOfficialRole": [
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Completed"
      ],
      "OversightHasDMC": [
            "Yes"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Not Applicable"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "December 2014"
      ],
      "PrimaryCompletionDateType": [
            "Actual"
      ],
      "PrimaryOutcomeDescription": [],
      "PrimaryOutcomeMeasure": [
            "the proportion of patients which disease activity reaches ASAS(assessment in ankylosing Spondylitis)20 remission criteria"
      ],
      "PrimaryOutcomeTimeFrame": [
            "24 weeks"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [
            "Sun Yat-sen University"
      ],
      "ResponsiblePartyInvestigatorFullName": [
            "Gu Jieruo"
      ],
      "ResponsiblePartyInvestigatorTitle": [
            "Department of Rheumatology, Third Affiliated Hospital of Sun Yat-sen University"
      ],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Principal Investigator"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [],
      "SecondaryOutcomeMeasure": [
            "BASDAI score comparing to baseline",
            "BASFI score comparing to baseline"
      ],
      "SecondaryOutcomeTimeFrame": [
            "24 weeks",
            "24 weeks"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "March 2012"
      ],
      "StartDateType": [],
      "StatusVerifiedDate": [
            "February 2015"
      ],
      "StdAge": [
            "Child",
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "October 18, 2012"
      ],
      "StudyFirstPostDateType": [
            "Estimate"
      ],
      "StudyFirstSubmitDate": [
            "October 10, 2012"
      ],
      "StudyFirstSubmitQCDate": [
            "October 16, 2012"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}